|Articles|December 15, 2003
Luxottica to buy 20% more shares in RayBan
Milan, Italy-Luxottica Group will launch a public offering to acquire an additional 20% of the outstanding shares of RayBan Sun Optics India after losing an appeal to the Securities Appellate Tribunal in India.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
3
Understanding meibomian gland dysfunction, neuropathic pain, and the evolving dry eye patient
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















